Design, synthesis, HER2 inhibition and anticancer evaluation of new substituted 1,5-dihydro-4,1-benzoxazepines

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Rozeman EA, Dekker TJA, Haanen J, Blank CU. Advanced melanoma: current treatment options, biomarkers, and future perspectives. Am J Clin Dermatol 2018;19:303–17.
   PubMed Web of Science ®Google Scholar
• Couto GK, Segatto NV, Oliveira TL, et al. The melding of drug screening platforms for melanoma. Front Oncol 2019;9:512.
   PubMed Web of Science ®Google Scholar
• Hendriks BS, Opresko LK, Wiley HS, Lauffenburger D. Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects. Cancer Res 2003;63:1130–7.
   PubMed Web of Science ®Google Scholar
• Yarden Y. The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities. Eur J Cancer 2001;37:3–8.
   PubMed Web of Science ®Google Scholar
• Victorino VJ, Campos FC, Herrera ACSA, et al. Overexpression of HER-2/neu protein attenuates the oxidative systemic profile in women diagnosed with breast cancer. Tumour Biol 2014;35:3025–34.
   PubMedGoogle Scholar
• Puhalla S, Brufsky A. Treatment of HER2-positive breast cancer: looking backwards briefly. Lancet Oncol 2013;14:1250–1.
   PubMed Web of Science ®Google Scholar
• Díaz-Gavilán M, Gómez-Vidal JA, Choquesillo-Lazarte D, et al. Synthesis and reactivity of (RS)-6-chloro-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)-7H- or 9Hpurines bearing a nitrobenzenesulfonyl group on the nitrogen atom. Tetrahedron 2007;63:5274–86.
   Web of Science ®Google Scholar
• Díaz-Gavilán M, Gómez-Vidal JA, Rodríguez-Serrano F, et al. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: preliminary cDNA microarray studies. Bioorg Med Chem Lett 2008;18:1457–60.
   PubMed Web of Science ®Google Scholar
• López-Cara LC, Conejo-García A, Marchal JA, et al. New (RS)-benzoxazepin-purines with antitumour activity: the chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine. Eur J Med Chem 2011;46:249–58.
   PubMed Web of Science ®Google Scholar
• Marchal JA, Carrasco E, Ramírez A, et al. Bozepinib, a novel small antitumour agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence. Drug Des Dev Ther 2013;7:1301–13.
   PubMed Web of Science ®Google Scholar
• Ramírez A, Boulaiz H, Morata-Tarifa C, et al. HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound. Oncotarget 2014;5:3590–606.
   PubMedGoogle Scholar
• Dias AdF, Scholl JN, Moritz CEJ, et al. New insights into cytotoxic mechanisms of bozepinib against glioblastoma. Eur J Pharm Sci 2021;162:105823.
   PubMed Web of Science ®Google Scholar
• Macherey AC, Dansette PM. Chapter 33: Biotransformations leading to toxic metabolites: chemical aspects. In: Camille Georges Wermuth, ed. The practice of medicinal chemistry. 3rd ed. New York, NY: Elsevier Academic Press; 2008: 674–696.
   Google Scholar
• Briguglio I, Piras S, Corona P, et al. Benzotriazole: an overview on its versatile biological behavior. Eur J Med Chem 2015;97:612–48.
   PubMed Web of Science ®Google Scholar
• Beauchard A, Jaunet AI, Murillo L, et al. Synthesis and antitumoral activity of novel thiazolobenzotriazole, thiazoloindolo[3,2-c]quinoline and quinolinoquinoline derivatives . Eur J Med Chem 2009;44:3858–65.
   PubMed Web of Science ®Google Scholar
• Díaz-Gavilán M, Rodríguez-Serrano F, Gómez-Vidal JA, et al. Synthesis of tetrahydrobenzoxazepine acetals with electron-withdrawing groups on the nitrogen atom. Novel scaffolds endowed with anticancer activity against breast cancer cells. Tetrahedron 2004;60:11547–57.
   Web of Science ®Google Scholar
• Ishikawa T, Seto M, Banno M, et al. Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold. J Med Chem 2011;54:8030–50.
   PubMed Web of Science ®Google Scholar
• Schrödinger. Schrödinger. New York, NY: LLC; 2009.
   Google Scholar
• Halgren TA, Murphy RB, Friesner RA, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 2004;47:1750–9.
   PubMed Web of Science ®Google Scholar
• Jespers W, Esguerra M, Åqvist J, Gutiérrez-de-Terán H. QligFEP: an automated workflow for small molecule free energy calculations in Q. J Cheminform 2019;11:26.
   PubMed Web of Science ®Google Scholar
• Marelius J, Kolmodin K, Feierberg I, Aqvist J. Q: a molecular dynamics program for free energy calculations and empirical valence bond simulations in biomolecular systems. J Mol Graph Model 1998;16:213–25.
   PubMed Web of Science ®Google Scholar
• King G, Warshel A. A surface constrained all-atom solvent model for effective simulations of polar solutions. J Chem Phys 1989;91:3647–61.
   Web of Science ®Google Scholar
• Lee FS, Warshel A. A local reaction field method for fast evaluation of long-range electrostatic interactions in molecular simulations. J Chem Phys 1992;97:3100–7.
   Web of Science ®Google Scholar
• Ryckaert JP, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 1977;23:327–41.
   Web of Science ®Google Scholar
• Robertson MJ, Tirado-Rives J, Jorgensen WL. Improved peptide and protein torsional energetics with the OPLSAA Force Field . J Chem Theory Comput 2015;11:3499–509.
   PubMed Web of Science ®Google Scholar
• Bennett CH. Efficient estimation of free energy differences from Monte Carlo data. J Comput Phys 1976;22:245–68.
   Web of Science ®Google Scholar
• Núñez MC, Pavani MG, Díaz-Gavilán M, et al. Synthesis and anticancer activity studies of novel 1-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)uracil and (6’-substituted)-7 or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H-or 9H-purines. Tetrahedron 2006;62:11724–33.
   Web of Science ®Google Scholar
• Kunte S, Abraham J, Montero AJ. Novel HER2-targeted therapies for HER2-positive metastatic breast cancer. Cancer 2020;126:4278–88.
   PubMed Web of Science ®Google Scholar
• Nahta R, Esteva FJ. HER2 therapy: molecular mechanisms of trastuzumab resistance. Breast Cancer Res 2006;8:215.
   PubMed Web of Science ®Google Scholar
• Javid J, Mir R, Julka PK, et al. Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients. Tumour Biol 2015;36:4253–60.
   PubMedGoogle Scholar
• Cáceres B, Ramirez A, Carrillo E, et al. Deciphering the mechanism of action involved in enhanced suicide gene colon cancer cell killer effect mediated by Gef and Apoptin. Cancers 2019;11:264.
   Web of Science ®Google Scholar
• Jiang M, Qi L, Li L, Li Y. The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov 2020;6:112.
   PubMed Web of Science ®Google Scholar
• Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009;10:241–7.
   PubMed Web of Science ®Google Scholar
• Ramos-Junior ES, Morandini AC. Gasdermin: a new player to the inflammasome game. Biomed J 2017;40:313–6.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 2017;547:99–103.
   PubMed Web of Science ®Google Scholar
• Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ 2019;26:99–114.
   PubMed Web of Science ®Google Scholar
• Rogers C, Fernandes-Alnemri T, Mayes L, et al. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun 2017;8:14128.
   PubMed Web of Science ®Google Scholar